iKnowMed Clear Value Plus, part of the Ontada (McKesson) suite of oncology technology solutions, is a clinical quality and regimen support tool designed specifically for oncologists and hematologists. It is widely recognized as the most-used oncology pathway technology by medical oncologists, relied upon by over 2,400 providers.
Product Overview and Key Benefits
Clear Value Plus is an integrated application that works seamlessly with the iKnowMed Electronic Health Record (EHR). Its primary function is to bring evidence-based treatment options to the point of care, ensuring that chosen therapies are consistent with nationally recognized clinical guidelines, such as the NCCN Clinical Practice Guidelines in Oncology® and Value Pathways powered by NCCN™. The content is updated rapidly (on average, 6.2 times per month) to keep pace with the fast-changing oncology landscape, including new biomarker-related data.
The tool is critical for practices participating in value-based care models, as it helps meet the requirements of programs like the Oncology Care Model (OCM) and the Merit-based Incentive Payment System (MIPS) Improvement Activities category. By documenting adherence to evidence-based treatments, it minimizes exposure to denied claims and reduces the administrative burden of prior authorizations.
Main Features and Capabilities
- Evidence-Based Treatment Recommendations: Provides real-time, point-of-care recommendations for chemotherapy regimens based on NCCN Guidelines and Value Pathways.
- Clinical Quality Support: Automatically records treatment decisions in the patient record of the integrated EHR (iKnowMed) to demonstrate quality of care.
- Prior Authorization Reduction: Eases the documentation burden by confirming regimen selections are on-guideline and on-pathway.
- Financial Transparency: Offers insights into the cost-effectiveness of different treatment options.
- Real-time Reporting: Provides key performance metrics such as adherence and regimen utilization history for individual providers or the entire practice.
- Biomarker Support: Intelligently prompts providers for relevant molecular results based on NCCN guidelines to support biomarker-directed care.
Target Users and Use Cases
- Target Users: Medical Oncologists, Hematologists, Oncology Nurses, and Community-Based Oncology Practices.
- Use Cases: Point-of-care treatment decision support, adherence to clinical pathways, streamlining prior authorization workflows, and maximizing success in value-based care programs.